Morningstar (NASDAQ:MORN) Cut to Hold at StockNews.com
Morningstar (NASDAQ:MORN – Get Free Report) was downgraded by stock analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Thursday. Several other research analysts have also commented on MORN. UBS Group initiated coverage on shares of Morningstar in a report on Tuesday, October 8th. They issued a “buy” […]
BIOLASE (NASDAQ:BIOL) Earns Sell Rating from Analysts at StockNews.com
StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL – Free Report) in a research report report published on Monday morning. The brokerage issued a sell rating on the medical technology company’s stock. Other analysts have also recently issued research reports about the stock. Benchmark reissued a “speculative buy” rating and issued a $0.40 price target […]
Masco (NYSE:MAS) Upgraded by StockNews.com to “Buy” Rating
Masco (NYSE:MAS – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Thursday. Several other research firms have also commented on MAS. BMO Capital Markets boosted their price target on Masco from $78.00 to $85.00 and gave the stock […]
Exact Sciences (NASDAQ:EXAS) Given New $67.00 Price Target at Robert W. Baird
Exact Sciences (NASDAQ:EXAS – Free Report) had its price target cut by Robert W. Baird from $70.00 to $67.00 in a research note issued to investors on Wednesday morning, Benzinga reports. They currently have an outperform rating on the medical research company’s stock. Several other analysts have also weighed in on the company. Wells Fargo […]
GlobalFoundries (NASDAQ:GFS) Given “Hold” Rating at Needham & Company LLC
Needham & Company LLC reaffirmed their hold rating on shares of GlobalFoundries (NASDAQ:GFS – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. Several other research analysts have also recently issued reports on GFS. Wedbush reiterated an “outperform” rating and issued a $60.00 price objective (down from $65.00) on shares of […]
Wells Fargo & Company Issues Positive Forecast for Emerson Electric (NYSE:EMR) Stock Price
Emerson Electric (NYSE:EMR – Free Report) had its price objective increased by Wells Fargo & Company from $128.00 to $135.00 in a research report sent to investors on Wednesday morning,Benzinga reports. Wells Fargo & Company currently has an overweight rating on the industrial products company’s stock. EMR has been the topic of several other research […]
Latham Group (NASDAQ:SWIM) Price Target Raised to $5.00 at The Goldman Sachs Group
Latham Group (NASDAQ:SWIM – Free Report) had its price target hoisted by The Goldman Sachs Group from $3.00 to $5.00 in a research note released on Wednesday, Benzinga reports. The firm currently has a sell rating on the stock. Other equities research analysts also recently issued reports about the company. Stifel Nicolaus increased their price […]
Entergy (NYSE:ETR) Upgraded at Morgan Stanley
Morgan Stanley upgraded shares of Entergy (NYSE:ETR – Free Report) from an underweight rating to an equal weight rating in a report issued on Monday morning, MarketBeat Ratings reports. They currently have $150.00 price target on the utilities provider’s stock, up from their prior price target of $116.00. A number of other analysts have also […]
Charter Communications (NASDAQ:CHTR) Price Target Raised to $415.00
Charter Communications (NASDAQ:CHTR – Free Report) had its target price hoisted by Morgan Stanley from $360.00 to $415.00 in a research note released on Monday morning, Benzinga reports. The firm currently has an equal weight rating on the stock. Several other equities research analysts have also recently issued reports on CHTR. Pivotal Research raised their […]
Celanese (NYSE:CE) Given New $100.00 Price Target at Morgan Stanley
Celanese (NYSE:CE – Free Report) had its target price reduced by Morgan Stanley from $140.00 to $100.00 in a research report released on Wednesday morning, Benzinga reports. Morgan Stanley currently has an equal weight rating on the basic materials company’s stock. CE has been the topic of a number of other research reports. KeyCorp cut […]
Bruker (NASDAQ:BRKR) Price Target Cut to $75.00 by Analysts at Wells Fargo & Company
Bruker (NASDAQ:BRKR – Free Report) had its price target lowered by Wells Fargo & Company from $78.00 to $75.00 in a research note published on Wednesday, Benzinga reports. The brokerage currently has an overweight rating on the medical research company’s stock. Other equities research analysts also recently issued research reports about the company. TD Cowen […]
Exact Sciences (NASDAQ:EXAS) Price Target Cut to $65.00 by Analysts at BTIG Research
Exact Sciences (NASDAQ:EXAS – Free Report) had its target price trimmed by BTIG Research from $82.00 to $65.00 in a report released on Wednesday morning, Benzinga reports. The firm currently has a buy rating on the medical research company’s stock. EXAS has been the subject of a number of other reports. Stifel Nicolaus reduced their […]
Charter Communications (NASDAQ:CHTR) Price Target Raised to $400.00
Charter Communications (NASDAQ:CHTR – Free Report) had its price objective boosted by JPMorgan Chase & Co. from $385.00 to $400.00 in a report issued on Monday, Benzinga reports. JPMorgan Chase & Co. currently has a neutral rating on the stock. CHTR has been the topic of several other research reports. Pivotal Research raised their price […]
Regeneron Pharmaceuticals (NASDAQ:REGN) Given New $1,000.00 Price Target at Oppenheimer
Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) had its target price reduced by Oppenheimer from $1,150.00 to $1,000.00 in a report released on Wednesday morning, Benzinga reports. Oppenheimer currently has an outperform rating on the biopharmaceutical company’s stock. REGN has been the subject of a number of other research reports. StockNews.com cut Regeneron Pharmaceuticals from a […]
Exact Sciences (NASDAQ:EXAS) Price Target Raised to $85.00
Exact Sciences (NASDAQ:EXAS – Get Free Report) had its price target increased by Jefferies Financial Group from $84.00 to $85.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the medical research company’s stock. Jefferies Financial Group’s price objective would indicate a potential upside of 56.14% from […]
PayPal (NASDAQ:PYPL) Upgraded to Buy at StockNews.com
StockNews.com upgraded shares of PayPal (NASDAQ:PYPL – Free Report) from a hold rating to a buy rating in a research report sent to investors on Sunday. A number of other brokerages also recently issued reports on PYPL. Macquarie increased their price target on PayPal from $90.00 to $95.00 and gave the stock an “outperform” rating […]
Visteon (NASDAQ:VC) Downgraded by StockNews.com to “Hold”
StockNews.com lowered shares of Visteon (NASDAQ:VC – Free Report) from a buy rating to a hold rating in a research note published on Sunday. A number of other research analysts have also recently commented on VC. Robert W. Baird restated a “neutral” rating and issued a $120.00 target price (down previously from $137.00) on shares […]
last updated on 8 Nov 07:28